Results 231 to 240 of about 3,808,290 (359)

DNA Replication Errors Drive Genome‐Wide Small Inverted Triplication Dynamics

Advanced Science, EarlyView.
This study provides insight into the dynamic equilibrium mechanism of a novel structural variant, small inverted triplication (SIT), which is generated by misalignment of the 3’ flap generated under DNA replication stress with palindromic sequence. Alternatively, the end sequence may fold back on itself to form an inverted fragment.
Yi Lei, Yu Zhou, Haitao Sun, Hang Yuan, Xinyu Pei, Jessica D. Hess, Yao Yan, Zunsong Hu, Mian Zhou, Zhaohui Gu, Li Zheng, Xiwei Wu, Binghui Shen   +12 more
wiley   +1 more source

Characterization of neocentromeric marker chromosome derived from chromosome 11: a rare entity in four patients with acute leukemia. [PDF]

Chromosome Res
Mendlikova I, Brezinova J, Svobodova K, Pavlistova L, Valerianova M, Valka J, Stastna MM, Jonasova A, Zemanova Z, Ransdorfova S.   +9 more
europepmc   +1 more source

Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia [PDF]

, 2017
et al.,, Uy, Geoffrey L
core   +2 more sources

Enhancing CAR‐T Cell Efficacy in Solid Tumors by Inhibiting CCL5/VEGF‐Mediated Angiogenesis

Advanced Science, EarlyView.
This study reveals that CAR‐T cells in solid tumors produce CCL5, which paradoxically induces VEGF and angiogenesis to promote tumor growth. Blocking CCL5/VEGF signaling—through gene knockout, or the CCR5 inhibitor maraviroc—significantly enhances the antitumor efficacy of CAR‑T therapy (the diagram was created in Biorender).
Shishuo Sun, Qihong Li, Bixi Wang, Gang Wang, Ying Xue, Yibing Liang, Chenhe Hu, Zhenyu Wang, Xiaoge Gao, Haiheng Xu, Jun Song, Hailong Li, Liantao Li, Xiaoxiao Liu, Patrick Ming‐Kuen Tang, Qing Zhang   +15 more
wiley   +1 more source

Dynamic changes in mortality risk factors for acute leukemia patients in the ICU and Post-ICU periods. [PDF]

Ann Hematol
Lu L, Liang Q, Yan Y, Tang Y, Wang E, Li Y, Zhang J, Xiao H, Cheng Q, Li X.   +9 more
europepmc   +1 more source

One‐Step Glycoengineering of NK Cells With High‐Affinity Siglec Ligands for Cancer Immunotherapy

Advanced Science, EarlyView.
This study develops an engineered NmCSS enzyme with improved activity for bulky group modified sialic acids, enabling efficient synthesis of structurally diverse sialoside analogs in a single step. Glycan microarray screening identified Siglec high‐affinity ligands, which were incorporated onto natural killer (NK) cells via a one‐pot enzymatic system ...
Shuai Hu, Ben Huang, Lingyan Wang, Qiang Guo, Cuiping Jiang, Ruicheng Qi, Shuyao Wang, Lin‐Tai Da, Wenjie Peng   +8 more
wiley   +1 more source

Mixed phenotype acute leukemia, the dissection of an enigmatic disease in the era of novel therapies. [PDF]

Front Pediatr
Karasek M, Kubiszewska I, Sobas M.
europepmc   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

Erratum to: Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard risk acute myeloid leukemia

Haematologica
Margarita Maurer-Granofszky, Stefan Köhrer, Susanna Fischer, Angela Schumich, Karin Nebral, Patrizia Larghero, Claus Meyer, Astrid Mecklenbräuker, Nora Mühlegger, Rolf Marschalek, Oskar A. Haas, Renate Panzer-Grümayer, Michael N. Dworzak   +12 more
doaj   +1 more source

Safety and feasibility assessment of implantable chest wall venous access port for patients with acute leukemia. [PDF]

Front Oncol
Ke P, Liao M, He F, Xu Y, Li G, Hu L, Feng C, Zhang R, Ding Y, Zhou J, Lu J, Cao Y.   +11 more
europepmc   +1 more source